The investigational drug arbaclofen makes autistic people’s brains respond to a visual task more like non-autistic people’s brains do.
Spectrum: Autism Research News
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
Motor differences are more relevant than has historically been appreciated for understanding, assessing and supporting people on the spectrum.
Developmental delay, intellectual disability and behavioral issues are common among people who have mutations in MYT1L, a gene with strong ties to autism.
In this edition of Null and Noteworthy, the Interagency Autism Coordinating Committee grapples with “groundbreaking” research and two reviews of interventions come to conflicting conclusions.
A potential new gene therapy delivered via a single injection mimics ratios of proteins normally found in cells.
Andrew Whitehouse talks about his conservation efforts in the Australian Outback, what it’s like to be an identical twin and why he leaves work promptly at 5 p.m.
Many autistic children rate the therapy as less effective at treating their anxiety than their parents and clinicians do.